PUBLIC CONTRACT · 2022
Medicamentos do grupo 4: sangue
- Contract value
- €77,127.00
- Signed on
- 4 March 2022
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 9046597PUBLISHED DESCRIPTION
221000121
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- AMGEN BIOFARMACEUTICA LDA · Tax ID 502942959
- Bidder
- OM PHARMA, SA · Tax ID 500207410
- Bidder
- Ferrer SA · Tax ID 500069190
- Bidder
- BAYER PORTUGAL LDA · Tax ID 500043256
- Bidder
- NOVARTIS FARMA - PRODUTOS FARMACEUTICOS, S.A. · Tax ID 500063524
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €77,127.00
- Procedure base price
- €532,668.71
- Total effective price
- Not reported on Portal BASE
- Publication date
- 8 March 2022
- Award date
- 17 February 2022
- Signing date
- 4 March 2022
- Performance period
- 323 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- CP 2020/18 - Medicamentos do grupo 4: sangue
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 5783457
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.